Pharmacist-led care pathway for type 2 diabetes in Alberta community pharmacies
Official title: Implementation and Evaluation of a Pharmacist-led Diabetes Care Pathway in Alberta Community Pharmacies.
Run by University of Alberta · NCT07339852 · Data updated 2026-11-12
This project will test whether a pharmacist-led care pathway in community pharmacies can help adults with type 2 diabetes and HbA1c above 7.0% lower their blood sugar and improve care compared with usual physician or nurse practitioner care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | University of Alberta Academic / other |
| Locations | 1 site (Edmonton, Alberta) |
| Status | Recruiting |
| Started | October 13, 2025 |
| Main results expected | October 1, 2026 |
| Study ends | October 1, 2026 |
| Registry record updated | January 14, 2026 |
| Trial ID | NCT07339852 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with type 2 diabetes whose HbA1c is above 7.0% and who can consent and attend follow-up visits are the intended participants.
✕Probably not a fit
People with type 1 or gestational diabetes, pregnant individuals, those already at HbA1c target under 7.0%, those with limited life expectancy or frailty, or those unable to consent or attend follow-ups are unlikely to benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with type 2 diabetes whose HbA1c is not at target will be enrolled and receive a structured pharmacist-led diabetes care pathway in community pharmacies. Pharmacists will provide medication review, shared decision-making, education, monitoring and follow-up visits, and coordinate with patients' primary care providers. Outcomes will include changes in HbA1c and management of cardiovascular risk factors such as blood pressure and lipids, measured over scheduled follow-ups. Results will be compared to usual care to see if the pharmacist-led approach improves glucose control and care processes.
Why it matters
Potential benefit: If successful, this could make it easier for people with type 2 diabetes to reach target blood sugar levels and lower their risk of diabetes-related complications.
How similar studies have gone: Previous pharmacist-led interventions have shown modest to meaningful improvements in HbA1c and medication management, so this approach builds on existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Individuals aged 18 years or older. 2. Individuals with type 2 diabetes. 3. Individuals with type 2 diabetes not reaching HbA1c target of under 7.0% Exclusion Criteria: 1. Individuals with type 1 diabetes, gestational diabetes, or other forms of diabetes that are not type 2 diabetes. 2. Pregnant individuals. 3. Individuals at their HbA1c target (HbA1c under 7.0%) or those with a limited life expectancy, frailty, or lack hypoglycemic awareness (i.e., those with an A1c target above 7.0%) . 4. Individuals unable to provide consent or who are unwilling to attend follow-up visits.
Where it's running
-
University of Alberta
Edmonton, Alberta, Canada Recruiting
Study contacts
- Principal investigator: Ross Tsuyuki, BScPharm, PharmD, MSc — University of Alberta
- Study coordinator: Stephanie Gysel, BScPharm, PharmD
- Email: sgysel@ualberta.ca
- Phone: 403-993-6678
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Linking social care with healthcare to help manage chronic diseases
This trial tests whether pairing patients with trained community health workers can help them get transportation, healthy food, information, and better access to care to improve health in conditions like hypertension, diabetes, and high cholesterol.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala
This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.
-
Goal-commitment coaching to boost proactive health actions in adults with hypertension, diabetes, or high cholesterol
This project will try a goal-commitment behavioral program to see if it helps adults with hypertension, diabetes, or high cholesterol adopt more proactive health habits.
-
Environmental and inflammatory links to metabolic and endocrine diseases
This project will see if combining environmental, genetic, and protein information can help predict early risk of diabetes, hypertension, and other metabolic or endocrine problems in community adults.
-
Taining Golden Lake comprehensive chronic disease management program
This project will build a large cohort of adults in Taining County to collect health data and try to create a county-level chronic disease management model for people with hypertension, diabetes, dyslipidemia, and other long-term conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.